AI Health Summit 2023 Speakers


Ms Anastasia Miros	Mr Benedict Tan
Director, Healthcare & Lifesciences (Asia Pacific), KPMG	Group Chief Digital Strategy Officer (GCDSO) \| Chief Data Officer (CDO), Division of Digital Strategy, Singapore Health Services (SingHealth)
Anastasia is passionate about partnering for outcomes, innovating for impact and delivering value for people across the healthcare ecosystem. Anastasia has over 20 years global and regional Life Sciences (MedTech, Pharma and Digital Health) and Private Healthcare experience within and with industry. Anastasia’s key technical focus areas include Digital Health and Innovation – digital strategy, digital commercial models, interoperability, data strategy and innovation, AI/ML and emerging technologies; New Business Models – growth strategy and models, ventures and partnership strategy, platform strategy, emerging models such as hospital in the home; and Commercialisation – NPD & BD, Advanced Manufacturing Market Access, Site Certification.	Benedict leads the development and implementation of SingHealth’s digital strategy to support SingHealth’s vision and mission. Benedict’s portfolio includes responsibilities for IT systems delivery and support, cybersecurity, data governance and management. He also drives the development of analytics capabilities and innovation platforms to address patients’ and staff’s needs. Benedict has over 30 years’ experience in the niche Healthcare and Information, Communications Technology area. He has played key leadership roles in public and private organisations and in implementing large-scale health IT and process reengineering projects including the Civil Service Medical Claims Reengineering initiative, SGH Bed Management and SingHealth Electronic Medical Records.


Dr Ben Johnson	Prof Carolyn Lam
Magazine Editor, Nature Medicine	Senior Consultant, Director of Women’s Heart Health, National Heart Centre Singapore \| Professor, Duke-NUS Medical School
Dr Johnson has been Magazine Editor at Nature Medicine since 2021, where he leads the news and opinion section and covers all specialities, from AI to global health. Prior to this, he was Head of Communities & Engagement at Springer Nature, where he managed the Nature Portfolio Communities, online engagement tools for researchers, and launched Nature’s Instagram account. Dr Johnson trained as a virologist at Public Health England, the University of Reading, and Imperial College London, U.K. He is an advisor to Health Data Research U.K., writes for Nature Biotechnology on health, and is based in London, U.K	Prof Lam is recognized globally for expertise in heart failure with preserved ejection fraction. She is a world-renowned clinical trialist, with her work as part of the global steering committees contributing to the first approved treatments for HFpEF to date. She was appointed to the 2021 European Society of Cardiology Heart Failure Guidelines Task Force and has published >300 articles in journals including NEFM, JAMA, Lancet and Circulation. In the field of MedTech, Prof Lam is co-founder of Us2.ai, an award-wining start-up dedicated to the automation of the fight against heart disease by applying artificial intelligence to echocardiography.


Prof K.G.M. (Carl) Moons Professor of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care, UMC Utrecht \| Figure Head AI of UMC Utrecht, Utrecht University, The Netherlands \| Professor and Director, Health Innovation Netherlands	Prof Catherine R. Lucey Executive Vice Chancellor and Provost (EVCP), University of California San Francisco (UCSF)
Prof Moons is also affiliated at VanderBilt University (US), convenor of Cochrane Prognosis Methods Group, and director of Health Innovation Netherlands which brings new medical innovations faster to the market. He is principal investigator in numerous international biomedical studies. His expertise is methods for design, conduct, analysis and reporting of studies on diagnostic and prognostic tests, devices, technology, (bio)markers and prediction models, in almost all medical domains. He leads large international consortia on reporting of AI algorithms (TRIPOD+AI) and on tools for assessing the quality of AI algorithms in medicine (PROBAST+AI). He has published over 650 peer-reviewed publications, and several books and book chapters on clinical research.	Catherine R. Lucey, MD, MACP leads the robust research enterprise and highly ranked academic programs at the University of California, San Francisco (UCSF) as Executive Vice Chancellor and Provost. She works closely with the Chancellor and leadership team to develop campus priorities and vision, maintain the University’s status as an international leader in health sciences education and research, and oversee external partnerships representing UCSF’s best interests. Her portfolio of work includes membership in the National Academy of Medicine, and past membership of the Board of Directors of the Association of American Medical Colleges, the American Board of Internal Medicine and the American Board of Medical Specialties.

Prof Chang-Fu Kuo Director, AI Centre \| Professor, Gout and Rheumatoid Arthritis, pharmacoepidemiology and genetic epidemiology \| Director, Department of Rheumatology, Allergy and Immunology \| Director of Medical Research and Development, Chang Gung Memorial Hospital Dr Kuo is a senior rheumatologist who holds multiple prestigious positions in the medical field. He is the director of the center for artificial intelligence in Medicine. Dr Kuo obtained his MD and Master's degree from Chang Gung University and his PhD from the University of Nottingham, UK. His research interests include the epidemiology of rheumatic diseases, genetic epidemiology of common complex diseases, pharmacoepidemiology, and medical artificial intelligence. He has published numerous papers on gout, covering various aspects such as epidemiology, treatment, prognosis, comorbidities, genetics, and risk factors. Dr Kuo has also developed new models to assess drug-drug interactions using routinely collected data.	Mr Chik Wai Chiew Chief Executive Officer and Executive Director, Heritas Capital Management Wai Chiew has over 25 years of experience in global investment management and strategic business development, leading various companies on transformational growth strategies, fundraising and M&A. He has expanded Heritas Capital’s private equity investment portfolio and initiated venture capital, fund-of-funds, and impact-first investments into healthcare, education, environment, and technology sectors globally. Wai Chiew has also overseen the integration of Environmental, Social and Governance considerations and impact investment mandates while building up Heritas’ multi-fund impact investment platform. In his previous roles at Temasek and other funds, Wai Chiew has led and managed investments across multiple industries and geographies, deploying capital for institutions and multiple family offices.

Mr Colin Lim

Prof Dai Qiong Hai

Chief Information Officer & Chief Data Officer, Ministry of Health, Singapore

Professor, Department of Automation, Tsinghua University | Dean, School of Information Science and Technology, Tsinghua University | Director, Institute of Brain and Cognitive Sciences, Tsinghua University| Academician, Chinese Academy of Engineering | Chairman, Chinese Association for Artificial Intelligence

Colin is the Chief Information Officer and Chief Data Officer of the Singapore Ministry of Health (MOH). Before joining MOH, Colin was the founder and CEO of mobilityX, a start-up funded by SMRT and Toyota Tsusho. He has experience in both the private sector (IBM UK and SMRT) and the public sector (Singapore Administrative Service, where he served in various ministries such as Home Affairs, Manpower, Transport as well as the Land Transport Authority). Colin graduated from the London School of Economics and Oxford University.

Prof Dai’s research centers on the interdisciplinary study of optics, informatics, neuroscience, and cognitive sciences, with hundreds of journal papers published. In the past decades, he has invented a series of mesoscale imaging systems and data analysis methods, facilitating simultaneous multi-scale observation of biological dynamics spanning from organelles, cells, tissue, and organs in different pathological or physiological states. His efforts opened a new horizon for the study of large-scale intercellular interactions, paving the way from brain sciences to artificial intelligence. Recently, he has been working on system neuroscience, artificial intelligence, computational imaging, large-scale data analysis methods, and neuromorphic optoelectronic devices.


Dr Ettikan Kandasamy Karuppiah	Dr Eyal Klang
Chief Technologist/Director, NVIDIA Asia Pacific South Region Dr. Ettikan Kandasamy Karuppiah, Chief Technologist/Director at NVIDIA Asia Pacific South Region works with innovators, researchers and techno-entrepreneurs to accelerate AI & GPU adaptation for their translational R&D and software solutioning needs. He has direct experience and passionate in accelerated computing, embedded software, autonomous systems, machine learning, deep learning, solution design and development covering end-to-end needs in various industry verticals. Currently he guides researchers/developers at customer/partner R&D centers and disruptive startups to implement actionable solutions for real world problems meeting specific requirements leveraging NVIDIA Software/Hardware. He has published numerous publications, patents and developed software libraries in past.	Head of the Sami Sagol AI Hub, ARC, Sheba Medical Center \| Radiologist, Abdominal Radiology Unit, Sheba Medical Center \| Adjunct Assistant Professor, Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai Dr. Eyal Klang, serves as the head of the Sami Sagol AI Hub at ARC and as a senior radiologist at the Department of Radiology at Sheba Medical Center's Abdominal Division. He was previously a two-year fellow in medical AI at Mount Sinai Hospital in New York and held the role of adjunct assistant professor of radiology at the Icahn School of Medicine at Mount Sinai. He continues to serve as a consultant in medical AI at Mount Sinai Hospital. With over 150 publications on PubMed, he is an active participant in numerous major grants and runs the DeepVision AI Lab at Sheba Medical Center.


Dr Goh Han Leong	Dr João Monteiro
Senior Principal Specialist, Synapxe	Chief Editor, Nature Medicine
Dr. Goh Han Leong is the senior principal specialist at Synapxe, Singapore’s national healthtech agency. At Synapxe, Dr. Goh leads the development of AI and data analytics solutions that can be used to better manage and improve healthcare services. He was awarded the National Commendation Medal (COVID-19) in 2022. In 2023, he assumed the role of Adjunct Senior Lecturer at the National University of Singapore (NUS), teaching students enrolled in the NUS Master of Science in the Business Analytics Programme.	Dr Monteiro is the Chief Editor of Nature Medicine, one of the top medical journals worldwide. He leads an international team covering news, opinion and research across the entire landscape of medical research. He has spoken about medicine, science and publishing in many international conferences, and has championed efforts to raise ethical standards and transparency in the reporting of translational and clinical research. João cares about supporting young investigators, creating opportunities to make scientific publishing more inclusive, and harnessing the potential of scientific research to reduce health inequalities globally.

Prof John CW Lim	Prof Joseph J.Y. Sung
Executive Director, Centre of Regulatory Excellence (CoRE), DukeNUS Medical School \| Chairman, Consortium for Clinical Research and Innovation Singapore	Senior Vice President, Health & Life Sciences, Nanyang Technological University \| Dean, Lee Kong Chian School of Medicine, Distinguished University Professor \| Chief Editor of the Journal of Gastroenterology and Hepatology
Prof Lim is founding Executive Director of the Duke-NUS Centre of Regulatory Excellence, Chairman of the Consortium for Clinical Research & Innovation Singapore, MOH Senior Advisor, and Policy Lead at the SingHealth Duke-NUS Global Health Institute. Formerly CEO of Singapore’s Health Sciences Authority and Deputy Director of Medical Services in MOH, he has also held other senior positions in Singapore’s Health and Education ministries. His current roles promote Asia-Pacific capacity building, scientific excellence, and health regulatory innovation. He chairs the US Pharmacopoeia’s Asia-Pacific Chapter and sits on the Singapore Food Agency Board and Singapore Medical Council, among others.	Prof Sung received his medical degree (MBBS) from The University of Hong Kong, and conferred PhD in biomedical sciences by the University of Calgary and MD by The Chinese University of Hong Kong. He holds fellowships from multiple organisations worldwide including the Royal Colleges of Physicians of Edinburgh, Glasgow, London, and Australia, the American College of Gastroenterology, the Hong Kong College of Physicians, Japan Gastroenterological Endoscopy Society and Academy of Medicine, Singapore. He has published over 1000 full scientific articles in leading medical and scientific journals and was listed as “Highly Cited Researchers” from 2018 to 2022 by Clarivate Analytics.




Prof Julian Savulescu	Dr Kenneth Ban
Chen Su Lan Centennial Professor in Medical Ethics, Yong Loo Lin School of Medicine, National University of Singapore Prof Julian Savulescu is the Chen Su Lan Professor in Medical Ethics at the National University of Singapore (NUS), where he directs the Centre for Biomedial Ethics. He is an award-winning ethicist and moral philosopher trained in neuroscience, medicine, and philosophy, going on to hold the Uehiro Chair in Practical Ethics (2002) at the University of Oxford, where he founded the Oxford Uehiro Centre for Practical Ethics in 2003, before moving to NUS in 2022. He is also a Distinguished Visiting Professorial Fellow at Murdoch Children’s Research institute and Melbourne Law School.	Program Director, Health/Biomedical Sciences, National Supercomputing Centre (NSCC) Singapore Kenneth obtained his BSc (Hons) in Biochemistry and MBBS degrees from the National University of Singapore (NUS) and a PhD in Cancer Biology from Stanford University. He completed his postdoctoral training at the Institute of Molecular and Cell Biology (IMCB) Singapore before joining NUS Medicine. He currently serves as the Phase I Director, overseeing the implementation of the medical sciences curriculum for first-year medical students. He also serves as the Program Director for Health/Biomedical Sciences at the National Supercomputing Centre (NSCC) Singapore, and Director of the NUS Medicine Bioinformatics Core Facility.


A/Prof Liu Nan	Dr Liu Yun
Associate Professor, Centre for Quantitative Medicine and Programme, Health Services and Systems Research, Duke-NUS Medical School Dr Liu Nan is an Associate Professor at the Centre for Quantitative Medicine and Programme in Health Services and Systems Research, Duke-NUS Medical School. Currently, he directs the Digital Medicine Lab. His expertise lies in explainable AI and trustworthy machine learning, applied to medical informatics, emergency care, cardiology, and health innovation. Recognized by Stanford and Elsevier as a World’s Top 2% Scientist, Dr Liu serves on the editorial boards of eminent journals like npj Digital Medicine, BMC Medicine, IEEE Journal of Biomedical and Health Informatics, and PLOS Digital Health	Staff Research Scientist, Google Research Dr Liu is a staff research scientist in Google Research. In this role he focuses on developing and validating machine learning for medical applications across multiple fields: pathology, ophthalmology, radiology, dermatology, and more. Dr Liu completed his PhD at Harvard-MIT Health Sciences and Technology, where he worked on predictive risk modeling using biomedical signals, medical text, and billing codes. He has previously also worked on predictive modeling for nucleic acid sequences and protein structures. Dr Liu completed a B.S. in Molecular and Cellular Biology and Computer Science at Johns Hopkins University.

Prof Ma Wei-Ying	Dr Ong Chen Hui
Huiyan Chair Professor, Tsinghua University \| Chief Scientist of the Institute for AI Industry Research (AIR), Tsinghua University Prof Ma’s research interests include several core areas of AI such as machine learning and natural language understanding and generation, as well as interdisciplinary research and applications of AI in life sciences, biopharmaceuticals, and precision medicine. He has published over 300 papers in world-class conferences and academic journals and holds more than 160 technological patents. Prof Ma previously served as Vice President and Head of AI Lab at ByteDance and Deputy Managing Director of Microsoft Research Asia.	Assistant Chief Executive, Business and Technology Group, Infocomm and Media Development Authority (IMDA) Dr Ong oversees IMDA’s efforts in industry development and research around emerging technologies. She initiated the Future Communications Programme to support 6G research, Digital Trust Centre for trust technology innovation, the 5G Innovation Programme to help industries adopt 5G, and launched Singapore’s AI Verify toolkit for AI governance. Dr Ong has more than 20 years of experience in R&D and technology innovation. She is the chair of Singapore’s Women in Tech, and serves on the Executive Committee of the Association of Infocomm Security Professionals. She is an honouree of Singapore 100 Women in Tech 2021.

Dr Pep Pàmies

Prof Peter Coveney

Chief Editor, Nature Biomedical Engineering

Dr Pàmies launched Nature Biomedical Engineering in 2017 after working as an editor for Nature Materials for over 5 years, where he championed biomaterials content, handling manuscripts and commissioning articles in a wide variety of subjects, including tissue engineering, medical imaging, regenerative medicine, cancer therapy and diagnostics. Previously, he conducted research in computational soft matter and biophysics at Columbia University's Chemistry Department, at the Max Planck Institute of Colloids and Interfaces, and at the Atomic and Molecular Physics Institute (Amsterdam). Dr Pàmies obtained his PhD in Chemical Engineering from Rovira i Virgili University in Catalonia, Spain.

Professor, University College London

Peter Coveney is a Professor of Physical Chemistry, Honorary Professor of Computer Science, and Director of the Centre for Computational Science (CCS) at University College London. He is a Fellow of the Royal Academy of Engineering and Member of Academia Europaea. Dr Coveney has made outstanding contributions across a wide range of scientific and engineering fields, including physics, chemistry, chemical engineering, materials, computer science, high performance computing and biomedicine, using supercomputing to conduct original research at unprecedented space and time scales. He leads these fields by running multiple initiatives and multi-partner interdisciplinary grants, in the UK, Europe and the US.


Mr Peter Wu	Dr Rama Sethuraman
CEO, ASUS Cloud & Taiwan Web Service Corporation (TWSC)	Director, Medical Devices , Medical Devices Cluster, Health Products Regulation Group, Health Sciences Authority (HSA)
With many years of experience in cloud services and smart medical innovation and entrepreneurship, Peter Wu is leading the establishment, development, and operation of the Taiwan Computing Cloud (TWCC) platform and Taiwania 2, creating the best ranking of international supercomputers and enhancing the capacity of Taiwan’s autonomous technology. He has led Taiwan Web Service Corporation (TWS) AIHPC Supercomputer and ASUS Cloud to become the leading brand of AI cloud, promoting integrated innovation in cloud, big data, internet of things, blockchain, 5G, and artificial intelligence, assisting IT and industry integration, and driving digital transformation.	Rama oversees pre-market registration and post-market controls for all medical devices in Singapore. She also oversees device development consultation that aims to support safe innovation in medical technologies. She has been working in Medical Device Regulations for over 14 years now. She represents Singapore as a member of the Management Committee of the International Medical Device Regulators Forum (IMDRF) and is the head of delegation for Singapore in the ASEAN Medical Device Committee (AMDC). Prior to joining the HSA, she was involved in Research on chronic neuropathic pain at NUS, identifying novel biomarkers related to pain and developing novel diagnostic methods using principles of chemistry in analysis of biological samples.




Adj Assoc/Prof (Dr) Raymond Chua	Dr Richa Tiwari
Deputy Director-General of Health, Health Regulation Group \| Assistant Commissioner, Cybersecurity (Healthcare), Ministry of Health, Singapore Adj Assoc/Prof (Dr) Raymond Chua is a Registered Public Health Specialist and Fellow with the Academy of Medicine. As Deputy Director-General of Health, he oversees the regulation of healthcare services, premises, and health digitalization in Singapore, to safeguard public health, assure patient safety and ensure healthcare innovations. He is concurrently designated as Assistant Commissioner for Cybersecurity in Healthcare, to assist in tracking and enhancing cybersecurity policies relating to Critical Information Infrastructures and Medical Devices in Singapore. He also chairs the Public Service Division’s Regulatory Advisory Group to provide guidance and broad direction in using regulatory tools and capability development of regulators in the public service.	APAC Program Manager, Google Health AI Dr Richa is a Program Manager at Google Health AI. Her work focuses on leading research implementation and deployment of AI solutions in healthcare in the APAC region. Richa has a background in healthcare, having worked in Pharma/Medical Affairs, bringing cancer treatments to market and running clinical trials. She has a PhD in Molecular Biology from The University of Texas at Austin (with a specialization in oncology) and a B.S. in Biology from Brandeis University.


Dr Rupa Sarkar	Dr Sebastian Maurer-Stroh
Editor-in-Chief, The Lancet Digital Health	Executive Director, Bioinformatics Institute (BII) A*STAR
Since Dr Sarkar’s appointment as the founding Editor-in-Chief in November 2018, The Lancet Digital Health has become the leading journal in the field of artificial intelligence and digital health, with a mission to advance standards for the next generation of health care technology. Dr Sarkar obtained her PhD in embryonic stem cell development from Imperial College London, U.K. Her interests span all interdisciplinary areas of digital health, with a particular interest in genomics and machine learning in clinical applications. She has delivered seminars at over 30 conferences in the USA, China, India, Europe, and UK.	Sebastian Maurer-Stroh graduated in theoretical biochemistry at the University of Vienna and obtained his master and PhD from the Institute of Molecular Pathology (IMP). After FEBS and Marie Curie fellowships at the VIB-SWITCH lab in Brussels, he has been leading the sequence analytics portfolio in the A*STAR Bioinformatics Institute (BII) since 2007. He is the Executive Director of BII since January 2021. His team had many successes in Precision Medicine, Consumer Product and Food Safety, and global viral pathogen surveillance through the GISAID initiative that has become the most important source for virus outbreak data sharing and analysis, powering public health responses globally.


Prof Simon Chesterman	Dean Thomas M. Coffman
Vice Provost (Educational Innovation), National University of Singapore \| Dean, NUS College \| David Marshall Professor, Senior Director (AI Governance), AI Singapore \| Editor, Asian Journal of International Law	Dean, Duke-NUS Medical School \| Professor, Cardiovascular and Metabolic Disorders Signature Research Programme (SRP), Duke-NUS Medical School \| James R. Clapp Professor of Medicine, Duke University Medical Centre
Prof Chesterman is a recognized authority on international law, whose work has opened new areas of research on conceptions of public authority — including the rules and institutions of global governance, state-building and post-conflict reconstruction, the changing role of intelligence agencies, and the emerging role of artificial intelligence and big data. A Rhodes scholar, Prof Chesterman obtained his PhD in International Law from the University of Oxford in 2000, and has taught at the Universities of Melbourne, Oxford, Southampton, Columbia, and Sciences Po.	Dean Coffman joined Duke-NUS in 2010 as Founding Director of the Cardiovascular and Metabolic Disorders SRP and was appointed Dean on July 2015. He is currently a member of the SingHealth Board of Directors. Dean Coffman’s research interests include the renin-angiotensin and prostanoid systems, and diabetic nephropathy. An international leader in the field of nephrology, he is a Past-President of the American Society of Nephrology and is also a member of the American Society for Clinical Investigation and the Association of American Physicians. Dean Coffman was conferred the 2014 Excellence Award for Hypertension Research from the American Heart Association Council.


Dr Wei-Chi Wu	Prof Wong Tien Yin
Professor, Ophthalmology, Chang Gung Memorial Hospital Wei-Chi Wu, MD, PhD, is currently the Professor of Ophthalmology at Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. He is currently the editor of Translational Vision Science & Technology and American Journal of Ophthalmology Case Report. After he finished his PhD at Chang Gung University, he completed his fellowship and Post-Doctorate Research with Dr. Michael Trese at William Beaumont Hospital, Royal Oak, Michigan, USA, with his research focus in the field of pediatric retina. He has won many awards for his contribution in the research of retinal disease, and authored for more than 320 papers, 7 book chapters, and edited one textbook.	Founding Head and Chair Professor, Tsinghua Medicine, Beijing, China \| Senior Advisor, SingHealth & Singapore National Eye Centre, Singapore Prof Wong is a senior academic ophthalmologist and physician-scientist. Prior to current his appointment at Tsinghua University, China, he was Arthur Lim Professor and Medical Director of the Singapore National Eye Center. Prof Wong is a retinal specialist, with a research portfolio on retinal diseases and ocular imaging, including AI. He has published >1,500 peer-reviewed papers. Prof Wong has served as a Board member of numerous professional organizations, including the International Council of Ophthalmology and the Asia Pacific Academy of Ophthalmology. He has been recognized with multiple international awards, including the Alcon Research Institute Award and the ARVO Friedenwald Award.


Dr Xiao (Xiaoxuan) Liu	Mr Yeong Zee Kin
Clinical Researcher in Artificial Intelligence and Digital Health Technologies, University Hospitals Birmingham \| Specialty Registrar in Ophthalmology	Chief Executive, Singapore Academy of Law
Dr Liu is an ophthalmologist and researcher with an interest in how AI and digital health technologies intersect with international health policy and regulation. Her research aims to ensure AI medical devices are safe, effective, and equitable. She advocates for transparency and accountability through her work on the SPIRIT-AI and CONSORT-AI reporting guidelines for clinical trials (www.clinical-trials.ai), the Medical Algorithmic Audit for clinical safety monitoring, and the STANDING Together project to tackle bias in health datasets to ensure AI benefits all (www.datadiversity.org). She has worked on health policy and AI technology regulation with institutions including the MHRA, NICE and WHO.	Zee Kin’s experience as a Technology, Media and Telecommunications lawyer spans both the private and public sectors. He has spoken and published in areas relating to electronic evidence and intellectual property, as well as legal issues relating to Blockchain and AI deployment. Zee Kin is an internationally recognized expert on AI ethics. He spearheaded the development of Singapore’s Model AI Governance Framework and is currently a member of the OECD Network of Experts on AI (ONE AI). He was a member of the AI Group of Experts at the OECD, which developed the OECD Principles on AI that were endorsed by the G20 in 2019.